HALO – halozyme therapeutics, inc. (US:NASDAQ)
Stock Stats
News
5/15
11:19 am
halo
Low
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
5/8
03:19 pm
halo
Low
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
02:42 pm
halo
Low
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JMP Securities from $72.00 to $71.00. They now have a "market outperform" rating on the stock.
5/8
11:40 am
halo
Low
Biopharmaceuticals Packaging Market Size Expected to Reach USD 42.08 Bn by 2032 Wed, May 8, 2024, 5:32 PM GMT+2 17 min read 0 Advertisement Up next Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates Wed, May 8, 2024, 4:34 PM GMT+2 3 min read 0 In
5/8
08:40 am
halo
Low
Halozyme to Participate in Upcoming Investor Conferences Wed, May 8, 2024, 2:30 PM GMT+2 2 min read 0 In this article: Advertisement Up next Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Wed, May 8, 2024, 12:00
5/7/2024
04:01 pm
HALO
1.9%
BEAT
2/20/2024
04:01 pm
HALO
6.6%
BEAT
11/6/2023
04:01 pm
HALO
10.0%
BEAT
8/8/2023
04:01 pm
HALO
-1.6%
BEAT
5/8
01:57 pm
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
-1.2%
5/8
01:57 pm
Maintains
Market Outperform
Market Outperform
JMP Securities
Low
-1.2%
5/7
08:01 am
Reiterates
Buy
Buy
HC Wainwright
Low
0.6%
4/30
08:12 am
Reiterates
Buy
Buy
HC Wainwright
Low
-1.7%
4/16
10:13 am
Reiterates
Buy
Buy
Benchmark Co.
Low
-0.1%
5/7
04:11 pm
halo
Low
Form 10-Q HALOZYME THERAPEUTICS, For: Mar 31
5/7
04:06 pm
halo
Low
Form 8-K HALOZYME THERAPEUTICS, For: May 07
4/29
06:11 pm
halo
Low
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Posard Matthew L.
4/29
06:08 pm
halo
Low
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: Miyashita Akiko Moni
4/29
06:06 pm
halo
Low
Form 4 HALOZYME THERAPEUTICS, For: Apr 25 Filed by: MATSUI CONNIE
Show more
Top News Gainers
11/12 Form 8-K/A HALOZYME THERAPEUTICS, For: Oct 30 21.4%
11/5 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $16.00 price target on the stock, down previously from $17.00. 10.6%
5/1 FDA OKs subcutaneous version of J&J's Darzalex [Seeking Alpha] 8.1%
3/20 Form DEFA14A HALOZYME THERAPEUTICS, 8.0%
1/9 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. 8.0%
4/3 Form 4 HALOZYME THERAPEUTICS, For: Apr 01 Filed by: Sun Elaine D 6.2%
1/14 Halozyme Provides 2020 Business Update And Financial Guidance 5.9%
1/8 Halozyme Therapeutics, Inc. (NASDAQ: HALO) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating on the stock. 5.4%
3/19 Form 4 HALOZYME THERAPEUTICS, For: Mar 19 Filed by: Kelley Kenneth J 4.5%
11/13 Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $400 Million of Convertible Senior Notes due 2024 4.5%
Top News Decliners
2/27 argenx SE (ARGX) Q4 2019 Earnings Call Transcript [The Motley Fool] -4.5%
4/3 Halozyme Announces Change Of Location Of Annual Stockholders' Meeting -4.4%
2/26 Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference -4.3%
5/13 Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019 -4.2%
8/8 Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -3.9%
8/6 Halozyme Reports Second Quarter 2019 Results -3.2%
9/4 Form 8-K HALOZYME THERAPEUTICS, For: Sep 04 -3.2%
2/25 Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JPMorgan Chase & Co. from $24.00 to $22.00. They now have an "overweight" rating on the stock. -3.0%
7/19 Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology -3.0%
7/3 Form SC 13D/A HALOZYME THERAPEUTICS Filed by: KIRK RANDAL J -2.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3